1996
DOI: 10.1007/bf00176279
|View full text |Cite
|
Sign up to set email alerts
|

Oblique excision with primary closure for the treatment of pilonidal sinus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1998
1998
2019
2019

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 23 publications
(15 reference statements)
0
3
0
Order By: Relevance
“…Further, data on recurrence and follow-up times pertaining to 3,121 patients receiving primary open PSD treatment were extracted from 28 additional non-RCTs 4 , 76 , 130 , 133 , 139 , 157 , 221 , 228 , 320 , 348 , 357 , 375 391 . Among these patients, a recurrence of 1.0% (95% CI 0.6–1.4%) was observed in patients at 12 months, 1.6% (95% CI 1.1–2.1%) at 24 months, 3.2% (95% CI 2.3–4.0%) at 60 months, and 6.7% (95% CI 5.2–8.2%) at 120 months (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Further, data on recurrence and follow-up times pertaining to 3,121 patients receiving primary open PSD treatment were extracted from 28 additional non-RCTs 4 , 76 , 130 , 133 , 139 , 157 , 221 , 228 , 320 , 348 , 357 , 375 391 . Among these patients, a recurrence of 1.0% (95% CI 0.6–1.4%) was observed in patients at 12 months, 1.6% (95% CI 1.1–2.1%) at 24 months, 3.2% (95% CI 2.3–4.0%) at 60 months, and 6.7% (95% CI 5.2–8.2%) at 120 months (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…at riskRR in % (95% CI)Nr. at riskPrimary open (143)2.7* (0.0–5.5)143*5.9* (1.4–10.4)120*NANANANA 32, 114, 118 Primary median closure (2902)0.8 (0.4–1.1)28187.0* (5.7–8.2)1383*18.8* (15.7–21.8)417*NANA 118, 127, 133, 136, 137, 139, 143, 148, 149, 158160, 169, 172174, 183, 192, 199– 201, 232, 242, 243, 246, 247, 597– 603 Primary asymmetric closure (727)1.7 (0.7–2.8)6212.5 (1.1–3.8)4037.4 (4.4–10.4)257NANA 183, 192, 253, 259, 261, 262 Karydakis/Bascom (2471)0.8 (0.4–1.1)23561.7* (1.1–2.4)1343*10.7 (7.4–13.9)257NANA 133, 172, 192, 199, 200, 262, 264, 267, 268, 270, 273, 274, 276, 279, 282, 284, 289– 292, 295, 296, 300, 305– 309, 603 Limberg/Dufourmentel (7653)0.1 (0.0–0.2)73691.1 (0.8–1.4)…”
Section: Resultsmentioning
confidence: 99%
“…at riskRR in % (95% CI)Nr. at riskPrimary open (6351)1.3 (1.0–1.7)57154.2 (3.6–4.8)349613.9 (12.2–15.6)122228.1* (23.9–32.4)241* 20122 Primary median closure (15011)3.1 (2.8–3.5)12,4848 (7.4–8.6)695614.9 (13.8–15.9)250527.9 (25.5–30.4)631 20, 24, 27, 29, 31, 3438, 44, 46, 48, 52, 54, 56, 57, 59, 6166, 69, 73– 78, 81– 84, 86, 89– 91, 93– 100, 106– 108, 115, 118, 122248 Primary asymmetric closure (2538)0.6 (0.3–0.9)24321.1 (0.7–1.6)18072.7 (1.9–3.6)12056.3* (4.8–7.7)937* 65, 67, 100, 129, 183, 192, 249263 Karydakis/Bascom (6276)0.5 (0.3–0.7)58681.6 (1.2–2.0)36306.3 (5.0–7.5)853NANA 16, 21, 29, 41, 49, 66, 78, 88, 133, 163, 172, 184, 189, 192, 195, 199, 200, 202, 262…”
Section: Introductionmentioning
confidence: 99%